ArticleThe American journal of case reports2023

Germline BRCA2 Pathogenic Variant in Primary Breast Cancer of a Down Syndrome Individual.

Tsuyoshi Shinohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.